Loading…
Effects of the Rho/Rho-Kinase Pathway on Perfusion Pressure in the Isolated-Perfused Rat Hind Limb Vascular Bed
Rho/ROCK signaling has been demonstrated to be involved in the vascular reactivity of many arterial networks. However, RhoA expression and the contribution of Rho/ROCK pathway to the control of perfusion pressure have not been investigated in the rat hind limb vascular bed as a skeletal muscle vascu...
Saved in:
Published in: | Balkan medical journal 2021-09, Vol.38 (5), p.304-309 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 309 |
container_issue | 5 |
container_start_page | 304 |
container_title | Balkan medical journal |
container_volume | 38 |
creator | İlhan, Esra Büyükafşar, Kansu Tiftik, R Nalan Seçilmiş, M Ata Alzayed, Zayed |
description | Rho/ROCK signaling has been demonstrated to be involved in the vascular reactivity of many arterial networks. However, RhoA expression and the contribution of Rho/ROCK pathway to the control of perfusion pressure have not been investigated in the rat hind limb vascular bed as a skeletal muscle vascular network.
To investigate the contribution of the Rho/ROCK pathway in the control of perfusion pressure in the isolated-perfused rat hind limb vascular bed.
Animal experimentation.
Two Rho inhibitors (atorvastatin and C3 exoenzyme) and ROCK inhibitors (Y-27632 and fasudil) were tested on the phenylephrine-elevated perfusion pressure in the isolated-perfused rat hind limb vascular bed. Furthermore, we sought the expression of RhoA protein in the femoral, popliteal and saphenous arteries as well as quadriceps and gastrocnemius muscles by Western blotting.
The ROCK inhibitors Y-27632 and fasudil (both 10-8 to 10-5 M) induced substantial vasodilatations. The maximum vasodilatations induced by Y-27632 and fasudil (both at 10-5 M) were 84.0 ± 6.9% and 76.9 ± 6.9%, respectively (P = .091). Y-27632 was not more potent than fasudil, as the EC50 values for Y-27632 and fasudil were 0.7 ± 2.1 μM and 2.5 ± 2.4 μM, respectively (P = .177). Atorvastatin (10-7 to 10-4 M) and C3 exoenzyme (3 × 10-8 M) also produced vasodilatation (maximum vasodilatation; 20.3 ± 1.7% and 13.7 ± 3.6%, respectively). The EC50 value for atorvastatin was 94.9 ± 1.2 μM. The western blot analysis showed that the femoral, saphenous, and popliteal arteries, as well as the gastrocnemius and quadriceps muscles, express RhoA protein.
The Rho/ROCK pathway contributes significantly to the control of perfusion pressure in the rat hind limb vascular bed. |
doi_str_mv | 10.5152/balkanmedj.2021.20014 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_64a06c1dc8064e878d7c8dd7b00b1a09</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A678962211</galeid><doaj_id>oai_doaj_org_article_64a06c1dc8064e878d7c8dd7b00b1a09</doaj_id><sourcerecordid>A678962211</sourcerecordid><originalsourceid>FETCH-LOGICAL-c492t-80475dfcc87922afe4ec6d9221878e413ce3682750b4ba5c395cf08f7523b423</originalsourceid><addsrcrecordid>eNptkt1q3DAQhU1paUKaR2gR9KY33ujf8k0hDWmyZKEhhN6asTTa1da2UstuydtXm01DFyoh6TA68zEaVBTvGV0opvhZC90PGHp02wWnnOWNMvmqOOZM6lIwwV6_aC6OitOUtjQPTYUU9dviSEiljGT6uIiX3qOdEomeTBskd5t4lld5EwZISG5h2vyGRxIHcoujn1PYqRFTmkckYXjKWabYwYSu3FvQkTuYyHUYHFmFviXfIdm5g5F8QfeueOOhS3j6fJ4U918v7y-uy9W3q-XF-aq0suZTaaislPPWmqrmHDxKtNplyUxlUDJhUWjDK0Vb2YKyolbWU-MrxUUruTgplnusi7BtHsbQw_jYRAjNUyCO6wbGKdgOGy2BasucNVRLzHhXWeNc1VLaMqB1Zn3esx7mNrfc4jCN0B1AD2-GsGnW8VdjjKGm3hXz6Rkwxp8zpqnpQ7LYdTBgnFPDVaW1qjjV2fpxb11DLi0MPmai3dmbc12ZWucOsOxa_MeVp8M-2DigDzl-kPDh3ye81P73H4g_7uy2mw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2576657206</pqid></control><display><type>article</type><title>Effects of the Rho/Rho-Kinase Pathway on Perfusion Pressure in the Isolated-Perfused Rat Hind Limb Vascular Bed</title><source>PubMed Central</source><creator>İlhan, Esra ; Büyükafşar, Kansu ; Tiftik, R Nalan ; Seçilmiş, M Ata ; Alzayed, Zayed</creator><creatorcontrib>İlhan, Esra ; Büyükafşar, Kansu ; Tiftik, R Nalan ; Seçilmiş, M Ata ; Alzayed, Zayed</creatorcontrib><description>Rho/ROCK signaling has been demonstrated to be involved in the vascular reactivity of many arterial networks. However, RhoA expression and the contribution of Rho/ROCK pathway to the control of perfusion pressure have not been investigated in the rat hind limb vascular bed as a skeletal muscle vascular network.
To investigate the contribution of the Rho/ROCK pathway in the control of perfusion pressure in the isolated-perfused rat hind limb vascular bed.
Animal experimentation.
Two Rho inhibitors (atorvastatin and C3 exoenzyme) and ROCK inhibitors (Y-27632 and fasudil) were tested on the phenylephrine-elevated perfusion pressure in the isolated-perfused rat hind limb vascular bed. Furthermore, we sought the expression of RhoA protein in the femoral, popliteal and saphenous arteries as well as quadriceps and gastrocnemius muscles by Western blotting.
The ROCK inhibitors Y-27632 and fasudil (both 10-8 to 10-5 M) induced substantial vasodilatations. The maximum vasodilatations induced by Y-27632 and fasudil (both at 10-5 M) were 84.0 ± 6.9% and 76.9 ± 6.9%, respectively (P = .091). Y-27632 was not more potent than fasudil, as the EC50 values for Y-27632 and fasudil were 0.7 ± 2.1 μM and 2.5 ± 2.4 μM, respectively (P = .177). Atorvastatin (10-7 to 10-4 M) and C3 exoenzyme (3 × 10-8 M) also produced vasodilatation (maximum vasodilatation; 20.3 ± 1.7% and 13.7 ± 3.6%, respectively). The EC50 value for atorvastatin was 94.9 ± 1.2 μM. The western blot analysis showed that the femoral, saphenous, and popliteal arteries, as well as the gastrocnemius and quadriceps muscles, express RhoA protein.
The Rho/ROCK pathway contributes significantly to the control of perfusion pressure in the rat hind limb vascular bed.</description><identifier>ISSN: 2146-3123</identifier><identifier>EISSN: 2146-3131</identifier><identifier>DOI: 10.5152/balkanmedj.2021.20014</identifier><identifier>PMID: 34558416</identifier><language>eng</language><publisher>Turkey: Galenos Yayinevi Tic. Ltd</publisher><subject>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives ; 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology ; Amides - pharmacology ; Animals ; Atorvastatin - pharmacology ; Extremities, Lower ; Health aspects ; Hemodynamics ; Isolation perfusion (Physiology) ; Leg ; Muscle Relaxants, Central - pharmacology ; Muscles ; Original ; Perfusion - methods ; Physiological aspects ; Protein kinases ; Pyridines - pharmacology ; Rats ; rho-Associated Kinases - metabolism ; rhoA GTP-Binding Protein - metabolism ; Vasodilation - drug effects ; Vasodilation - physiology ; Vasodilator Agents - pharmacology</subject><ispartof>Balkan medical journal, 2021-09, Vol.38 (5), p.304-309</ispartof><rights>COPYRIGHT 2021 Galenos Yayinevi Tic. Ltd.</rights><rights>Copyright 2021 authors 2021 authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880892/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880892/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34558416$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>İlhan, Esra</creatorcontrib><creatorcontrib>Büyükafşar, Kansu</creatorcontrib><creatorcontrib>Tiftik, R Nalan</creatorcontrib><creatorcontrib>Seçilmiş, M Ata</creatorcontrib><creatorcontrib>Alzayed, Zayed</creatorcontrib><title>Effects of the Rho/Rho-Kinase Pathway on Perfusion Pressure in the Isolated-Perfused Rat Hind Limb Vascular Bed</title><title>Balkan medical journal</title><addtitle>Balkan Med J</addtitle><description>Rho/ROCK signaling has been demonstrated to be involved in the vascular reactivity of many arterial networks. However, RhoA expression and the contribution of Rho/ROCK pathway to the control of perfusion pressure have not been investigated in the rat hind limb vascular bed as a skeletal muscle vascular network.
To investigate the contribution of the Rho/ROCK pathway in the control of perfusion pressure in the isolated-perfused rat hind limb vascular bed.
Animal experimentation.
Two Rho inhibitors (atorvastatin and C3 exoenzyme) and ROCK inhibitors (Y-27632 and fasudil) were tested on the phenylephrine-elevated perfusion pressure in the isolated-perfused rat hind limb vascular bed. Furthermore, we sought the expression of RhoA protein in the femoral, popliteal and saphenous arteries as well as quadriceps and gastrocnemius muscles by Western blotting.
The ROCK inhibitors Y-27632 and fasudil (both 10-8 to 10-5 M) induced substantial vasodilatations. The maximum vasodilatations induced by Y-27632 and fasudil (both at 10-5 M) were 84.0 ± 6.9% and 76.9 ± 6.9%, respectively (P = .091). Y-27632 was not more potent than fasudil, as the EC50 values for Y-27632 and fasudil were 0.7 ± 2.1 μM and 2.5 ± 2.4 μM, respectively (P = .177). Atorvastatin (10-7 to 10-4 M) and C3 exoenzyme (3 × 10-8 M) also produced vasodilatation (maximum vasodilatation; 20.3 ± 1.7% and 13.7 ± 3.6%, respectively). The EC50 value for atorvastatin was 94.9 ± 1.2 μM. The western blot analysis showed that the femoral, saphenous, and popliteal arteries, as well as the gastrocnemius and quadriceps muscles, express RhoA protein.
The Rho/ROCK pathway contributes significantly to the control of perfusion pressure in the rat hind limb vascular bed.</description><subject>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives</subject><subject>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology</subject><subject>Amides - pharmacology</subject><subject>Animals</subject><subject>Atorvastatin - pharmacology</subject><subject>Extremities, Lower</subject><subject>Health aspects</subject><subject>Hemodynamics</subject><subject>Isolation perfusion (Physiology)</subject><subject>Leg</subject><subject>Muscle Relaxants, Central - pharmacology</subject><subject>Muscles</subject><subject>Original</subject><subject>Perfusion - methods</subject><subject>Physiological aspects</subject><subject>Protein kinases</subject><subject>Pyridines - pharmacology</subject><subject>Rats</subject><subject>rho-Associated Kinases - metabolism</subject><subject>rhoA GTP-Binding Protein - metabolism</subject><subject>Vasodilation - drug effects</subject><subject>Vasodilation - physiology</subject><subject>Vasodilator Agents - pharmacology</subject><issn>2146-3123</issn><issn>2146-3131</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkt1q3DAQhU1paUKaR2gR9KY33ujf8k0hDWmyZKEhhN6asTTa1da2UstuydtXm01DFyoh6TA68zEaVBTvGV0opvhZC90PGHp02wWnnOWNMvmqOOZM6lIwwV6_aC6OitOUtjQPTYUU9dviSEiljGT6uIiX3qOdEomeTBskd5t4lld5EwZISG5h2vyGRxIHcoujn1PYqRFTmkckYXjKWabYwYSu3FvQkTuYyHUYHFmFviXfIdm5g5F8QfeueOOhS3j6fJ4U918v7y-uy9W3q-XF-aq0suZTaaislPPWmqrmHDxKtNplyUxlUDJhUWjDK0Vb2YKyolbWU-MrxUUruTgplnusi7BtHsbQw_jYRAjNUyCO6wbGKdgOGy2BasucNVRLzHhXWeNc1VLaMqB1Zn3esx7mNrfc4jCN0B1AD2-GsGnW8VdjjKGm3hXz6Rkwxp8zpqnpQ7LYdTBgnFPDVaW1qjjV2fpxb11DLi0MPmai3dmbc12ZWucOsOxa_MeVp8M-2DigDzl-kPDh3ye81P73H4g_7uy2mw</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>İlhan, Esra</creator><creator>Büyükafşar, Kansu</creator><creator>Tiftik, R Nalan</creator><creator>Seçilmiş, M Ata</creator><creator>Alzayed, Zayed</creator><general>Galenos Yayinevi Tic. Ltd</general><general>Trakya University School of Medicine</general><general>Galenos Publishing House</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210901</creationdate><title>Effects of the Rho/Rho-Kinase Pathway on Perfusion Pressure in the Isolated-Perfused Rat Hind Limb Vascular Bed</title><author>İlhan, Esra ; Büyükafşar, Kansu ; Tiftik, R Nalan ; Seçilmiş, M Ata ; Alzayed, Zayed</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c492t-80475dfcc87922afe4ec6d9221878e413ce3682750b4ba5c395cf08f7523b423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives</topic><topic>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology</topic><topic>Amides - pharmacology</topic><topic>Animals</topic><topic>Atorvastatin - pharmacology</topic><topic>Extremities, Lower</topic><topic>Health aspects</topic><topic>Hemodynamics</topic><topic>Isolation perfusion (Physiology)</topic><topic>Leg</topic><topic>Muscle Relaxants, Central - pharmacology</topic><topic>Muscles</topic><topic>Original</topic><topic>Perfusion - methods</topic><topic>Physiological aspects</topic><topic>Protein kinases</topic><topic>Pyridines - pharmacology</topic><topic>Rats</topic><topic>rho-Associated Kinases - metabolism</topic><topic>rhoA GTP-Binding Protein - metabolism</topic><topic>Vasodilation - drug effects</topic><topic>Vasodilation - physiology</topic><topic>Vasodilator Agents - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>İlhan, Esra</creatorcontrib><creatorcontrib>Büyükafşar, Kansu</creatorcontrib><creatorcontrib>Tiftik, R Nalan</creatorcontrib><creatorcontrib>Seçilmiş, M Ata</creatorcontrib><creatorcontrib>Alzayed, Zayed</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Balkan medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>İlhan, Esra</au><au>Büyükafşar, Kansu</au><au>Tiftik, R Nalan</au><au>Seçilmiş, M Ata</au><au>Alzayed, Zayed</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of the Rho/Rho-Kinase Pathway on Perfusion Pressure in the Isolated-Perfused Rat Hind Limb Vascular Bed</atitle><jtitle>Balkan medical journal</jtitle><addtitle>Balkan Med J</addtitle><date>2021-09-01</date><risdate>2021</risdate><volume>38</volume><issue>5</issue><spage>304</spage><epage>309</epage><pages>304-309</pages><issn>2146-3123</issn><eissn>2146-3131</eissn><abstract>Rho/ROCK signaling has been demonstrated to be involved in the vascular reactivity of many arterial networks. However, RhoA expression and the contribution of Rho/ROCK pathway to the control of perfusion pressure have not been investigated in the rat hind limb vascular bed as a skeletal muscle vascular network.
To investigate the contribution of the Rho/ROCK pathway in the control of perfusion pressure in the isolated-perfused rat hind limb vascular bed.
Animal experimentation.
Two Rho inhibitors (atorvastatin and C3 exoenzyme) and ROCK inhibitors (Y-27632 and fasudil) were tested on the phenylephrine-elevated perfusion pressure in the isolated-perfused rat hind limb vascular bed. Furthermore, we sought the expression of RhoA protein in the femoral, popliteal and saphenous arteries as well as quadriceps and gastrocnemius muscles by Western blotting.
The ROCK inhibitors Y-27632 and fasudil (both 10-8 to 10-5 M) induced substantial vasodilatations. The maximum vasodilatations induced by Y-27632 and fasudil (both at 10-5 M) were 84.0 ± 6.9% and 76.9 ± 6.9%, respectively (P = .091). Y-27632 was not more potent than fasudil, as the EC50 values for Y-27632 and fasudil were 0.7 ± 2.1 μM and 2.5 ± 2.4 μM, respectively (P = .177). Atorvastatin (10-7 to 10-4 M) and C3 exoenzyme (3 × 10-8 M) also produced vasodilatation (maximum vasodilatation; 20.3 ± 1.7% and 13.7 ± 3.6%, respectively). The EC50 value for atorvastatin was 94.9 ± 1.2 μM. The western blot analysis showed that the femoral, saphenous, and popliteal arteries, as well as the gastrocnemius and quadriceps muscles, express RhoA protein.
The Rho/ROCK pathway contributes significantly to the control of perfusion pressure in the rat hind limb vascular bed.</abstract><cop>Turkey</cop><pub>Galenos Yayinevi Tic. Ltd</pub><pmid>34558416</pmid><doi>10.5152/balkanmedj.2021.20014</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2146-3123 |
ispartof | Balkan medical journal, 2021-09, Vol.38 (5), p.304-309 |
issn | 2146-3123 2146-3131 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_64a06c1dc8064e878d7c8dd7b00b1a09 |
source | PubMed Central |
subjects | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology Amides - pharmacology Animals Atorvastatin - pharmacology Extremities, Lower Health aspects Hemodynamics Isolation perfusion (Physiology) Leg Muscle Relaxants, Central - pharmacology Muscles Original Perfusion - methods Physiological aspects Protein kinases Pyridines - pharmacology Rats rho-Associated Kinases - metabolism rhoA GTP-Binding Protein - metabolism Vasodilation - drug effects Vasodilation - physiology Vasodilator Agents - pharmacology |
title | Effects of the Rho/Rho-Kinase Pathway on Perfusion Pressure in the Isolated-Perfused Rat Hind Limb Vascular Bed |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T02%3A38%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20the%20Rho/Rho-Kinase%20Pathway%20on%20Perfusion%20Pressure%20in%20the%20Isolated-Perfused%20Rat%20Hind%20Limb%20Vascular%20Bed&rft.jtitle=Balkan%20medical%20journal&rft.au=%C4%B0lhan,%20Esra&rft.date=2021-09-01&rft.volume=38&rft.issue=5&rft.spage=304&rft.epage=309&rft.pages=304-309&rft.issn=2146-3123&rft.eissn=2146-3131&rft_id=info:doi/10.5152/balkanmedj.2021.20014&rft_dat=%3Cgale_doaj_%3EA678962211%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c492t-80475dfcc87922afe4ec6d9221878e413ce3682750b4ba5c395cf08f7523b423%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2576657206&rft_id=info:pmid/34558416&rft_galeid=A678962211&rfr_iscdi=true |